Latest Articles

Publication Date
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire

Published: Aug. 13, 2025, 8:17 p.m.
Aspira Women's Health Inc. SEC 10-Q Report - TradingView

Aspira Women's Health Inc. SEC 10-Q Report TradingView

Published: Aug. 13, 2025, 10:03 a.m.
Can a trend reversal in Distoken Acquisition Corporation Equity Right lead to recovery - Market Activity Report & Fast Moving Stock Watchlists - Newser

Can a trend reversal in Distoken Acquisition Corporation Equity Right lead to recovery - Market Activity Report & Fast Moving Stock Watchlists Newser

Published: Aug. 13, 2025, 5:01 a.m.
Advanced Endometrial Cancer Pipeline Outlook Report 2025: Key 25+ Companies and Breakthrough Therapies Shaping the Future Landscape - Barchart.com

Advanced Endometrial Cancer Pipeline Outlook Report 2025: Key 25+ Companies and Breakthrough Therapies Shaping the Future Landscape Barchart.com

Published: Aug. 12, 2025, 10:38 p.m.
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView

Karyopharm Therapeutics Inc. SEC 10-Q Report TradingView

Published: Aug. 11, 2025, 11:43 a.m.
Multimodal imaging features of high-grade endometrial stromal sarcoma with pulmonary and nodal metastases: A case report and literature review - Frontiers

Multimodal imaging features of high-grade endometrial stromal sarcoma with pulmonary and nodal metastases: A case report and literature review Frontiers

Published: Aug. 11, 2025, 9:32 a.m.
Endometrial Carcinoma in a 26-Year-Old Obese Woman With Polycystic Ovary Syndrome: A Case Report - Cureus

Endometrial Carcinoma in a 26-Year-Old Obese Woman With Polycystic Ovary Syndrome: A Case Report Cureus

Published: Aug. 8, 2025, 1:57 p.m.
Recurrent Hemothorax and Hemoperitoneum in Endometriosis: A Case Report - Cureus

Recurrent Hemothorax and Hemoperitoneum in Endometriosis: A Case Report Cureus

Published: Aug. 6, 2025, 9:17 p.m.
Gates Foundation to Spend $2.5 Billion on Women’s Health by 2030 - U.S. News & World Report

Gates Foundation to Spend $2.5 Billion on Women’s Health by 2030 U.S. News & World Report

Published: Aug. 6, 2025, 1:40 p.m.
Low-grade endometrial stromal sarcoma: a case report and literature review - Frontiers

Low-grade endometrial stromal sarcoma: a case report and literature review Frontiers

Published: Aug. 5, 2025, 7:58 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!